StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.67−0.23 (-12.08%)

Close on Nov 17, 2026Market cap $1.37MP/E –Yield –

Genprex total assets

Total assets on the balance sheet at the end of each period.

Genprex's total assets was $17.14M at Jun 30, 2026. For fiscal 2025 it was $10.16M, up 146.3% from the year before. The highest annual figure on record is $42.86M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.16M+146.3%
FY2024Dec 31, 2024$4.12M-61.3%
FY2023Dec 31, 2023$10.67M-57.5%
FY2022Dec 31, 2022$25.09M-41.5%
FY2021Dec 31, 2021$42.86M+36.6%
FY2020Dec 31, 2020$31.37M+787.5%
FY2019Dec 31, 2019$3.53M-61.9%
FY2018Dec 31, 2018$9.27M+635.9%
FY2017Dec 31, 2017$1.26M-34.1%
FY2016Dec 31, 2016$1.91M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.14M+347.7%
Q1 FY2026Mar 31, 2026$20.31M+237.9%
Q4 FY2025Dec 31, 2025$10.16M+146.3%
Q3 FY2025Sep 30, 2025$3.56M-8.8%
Q2 FY2025Jun 30, 2025$3.83M-42.0%
Q1 FY2025Mar 31, 2025$6.01M-52.2%
Q4 FY2024Dec 31, 2024$4.12M-61.3%
Q3 FY2024Sep 30, 2024$3.91M-76.5%
Q2 FY2024Jun 30, 2024$6.60M-58.5%
Q1 FY2024Mar 31, 2024$12.56M-46.1%
Q4 FY2023Dec 31, 2023$10.67M-57.5%
Q3 FY2023Sep 30, 2023$16.64M-44.4%
Q2 FY2023Jun 30, 2023$15.91M-54.0%
Q1 FY2023Mar 31, 2023$23.32M-40.8%
Q4 FY2022Dec 31, 2022$25.09M-41.5%
Q3 FY2022Sep 30, 2022$29.95M-35.4%
Q2 FY2022Jun 30, 2022$34.57M-29.1%
Q1 FY2022Mar 31, 2022$39.41M-22.8%
Q4 FY2021Dec 31, 2021$42.86M+36.6%
Q3 FY2021Sep 30, 2021$46.33M+98.4%
Q2 FY2021Jun 30, 2021$48.73M+96.9%
Q1 FY2021Mar 31, 2021$51.04M+107.1%
Q4 FY2020Dec 31, 2020$31.37M+787.5%
Q3 FY2020Sep 30, 2020$23.35M+474.0%
Q2 FY2020Jun 30, 2020$24.75M+295.1%
Q1 FY2020Mar 31, 2020$24.64M+229.6%
Q4 FY2019Dec 31, 2019$3.53M-61.9%
Q3 FY2019Sep 30, 2019$4.07M-63.2%
Q2 FY2019Jun 30, 2019$6.26M-51.4%
Q1 FY2019Mar 31, 2019$7.48M+439.3%
Q4 FY2018Dec 31, 2018$9.27M+635.9%
Q3 FY2018Sep 30, 2018$11.05M+772.2%
Q2 FY2018Jun 30, 2018$12.89M+574.7%
Q1 FY2018Mar 31, 2018$1.39M–
Q4 FY2017Dec 31, 2017$1.26M–
Q3 FY2017Sep 30, 2017$1.27M–
Q4 FY2016Dec 31, 2016$1.91M–

More Genprex figures

See a number that looks wrong?